104 related articles for article (PubMed ID: 7967070)
1. [Serum biochemical parameters in osteoporosis].
Tomita A
Nihon Rinsho; 1994 Sep; 52(9):2291-4. PubMed ID: 7967070
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical findings in serum of osteoporosis].
Tomita A
Nihon Rinsho; 1990 Dec; 48(12):2838-44. PubMed ID: 2086842
[No Abstract] [Full Text] [Related]
3. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical markers of bone remodelling and their usefulness in the diagnosis of osteoporosis].
Marcinowska-Suchowierska E; Lisawa A; Marowska J; Lorencewicz Z; Tałałaj M; Brzozowski R; Lorenc R
Wiad Lek; 1992 Sep; 45(17-18):647-54. PubMed ID: 1295248
[TBL] [Abstract][Full Text] [Related]
5. PTH bioactivity in osteoporosis.
Saphier PW; Stamp TC; Kelsey CR; Loveridge N
Bone Miner; 1987 Oct; 3(1):75-83. PubMed ID: 3505195
[TBL] [Abstract][Full Text] [Related]
6. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of bone turnover in osteoporosis.
Delmas PD; Beaudreuil J
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):31S-36S. PubMed ID: 9273935
[No Abstract] [Full Text] [Related]
8. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
9. Serum prolidase activity in postmenopausal osteoporosis.
Namiduru ES; Binnur Erbagci A; Celik A; Yilmaz M; Tarakçioglu M
Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of the alkaline (ALP) and acid phosphatase (ACP) in the blood serum of rats during experimental postmenopausal osteoporosis].
Rahnama M; Swiatkowski W; Zareba S
Rocz Panstw Zakl Hig; 2002; 53(3):283-91. PubMed ID: 12621884
[TBL] [Abstract][Full Text] [Related]
11. Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis.
Nawawi HM; Yazid TN; Ismail NM; Mohamad AR; Nirwana SI; Khalid BA
Malays J Pathol; 2001 Dec; 23(2):79-88. PubMed ID: 12166596
[TBL] [Abstract][Full Text] [Related]
12. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum and saliva calcium, phosphorus and alkaline phosphatase with dry mouth feeling in menopause.
Agha-Hosseini F; Mirzaii-Dizgah I; Moosavi MS
Gerodontology; 2012 Jun; 29(2):e1092-7. PubMed ID: 22260185
[TBL] [Abstract][Full Text] [Related]
14. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
15. [Involutional osteopathies: the clinical x-ray, biochemical and hormonal aspects of the diagnosis].
Bukhman AI; Zarubina NA; Dorokhova II; Kniazeva AP; Konnova EV
Probl Endokrinol (Mosk); 1988; 34(4):7-12. PubMed ID: 3194359
[TBL] [Abstract][Full Text] [Related]
16. [Bone and bone related biochemical examinations. Significance of measurement of serum calcium, phosphorus, alkaline phosphatase, corrected calcium and urine calcium].
Fujita T
Clin Calcium; 2006 Jun; 16(6):898-903. PubMed ID: 16751683
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of a biochemical index for the estimation of bone demineralization and dual photon absorptiometry.
Beer R; Barnhill SD; Madyastha KR
Contemp Orthop; 1995 Mar; 30(3):230-4. PubMed ID: 10150317
[TBL] [Abstract][Full Text] [Related]
20. [Effects of invigorating the kidney and strengthening the bones capsule on osteoporosis in ovariectomized rats].
Li S; Yang X; Yu D; Zhu A
Zhong Yao Cai; 2002 Jul; 25(7):489-91. PubMed ID: 12599761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
